DrugPatentWatch Database Preview
INTRON A Drug Profile
Summary for Tradename: INTRON A
| Patents: | 1250 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for INTRON A |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for INTRON A |
Recent Clinical Trials for INTRON A
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Editas Medicine, Inc. | Phase 1/Phase 2 |
| Allergan | Phase 1/Phase 2 |
| RWTH Aachen University | Phase 2 |
Recent Litigation for INTRON A
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Bay State Milling Company v. Arcadia Biosciences, Inc. | 2019-04-01 |
| Boston Heart Diagnostics Corporation v. MD Labs, Inc. | 2018-01-05 |
| Boston Heart Diagnostics Corporation v. Genelex Corporation | 2017-08-01 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Regeneron Pharmaceuticals, Inc. | 2019-09-20 |
| Baylor College of Medicine | 2018-04-18 |
| Guardant Health, Inc. | 2017-05-17 |
Pharmacology for INTRON A
| Ingredient-type | Interferon Alfa-2b Interferon-alpha |
Company Disclosures: US Patents for INTRON A
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Schering Corporation (Madison, NJ) | 2002-11-19 | RX | company | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Biogen N.V. (Curacao, AN) | 2002-07-23 | RX | company | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Schering Corporation (Kenilworth, NJ) | 2039-03-29 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for INTRON A
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | IDENIX PHARMACEUTICALS LLC (Cambridge, MA) | 2039-02-26 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Cipla Limited (Mumbia, IN) | 2035-12-09 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for INTRON A
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 0886641 | Start Trial |
| Israel | 119657 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007022335 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for INTRON A
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 3/2010 | Austria | Start Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 |
| 10C0004 | France | Start Trial | PRODUCT NAME: HORMONE FOLLICULO-STIMULANTE COMPRENANT UNE EXTENSION CTP, NOTAMMENT LA CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE IN FRANCE: EU/1/09/609/001 DU 20100125; REGISTRATION NO/DATE AT EEC: EU/1/09/609/001 DU 20100125 |
| 122010000006 | Germany | Start Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
